Tech Company Financing Transactions

Avalyn Pharma Funding Round

Eventide Asset Management, Perceptive Xontogeny Venture Fund and SR One Capital Management participated in a $175 million Series C funding round for Avalyn Pharma. The funding round was announced on 9/27/2023.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series C
Proceeds Purpose
The company plans to use the funds to continue development of its portfolio of inhalation therapies for interstitial lung disease that improve upon currently approved medications, and advance lead clinical assets, AP01 (inhaled pirfenidone) and AP02 (inhaled nintedanib), into mid-stage clinical trials.

Company Information

Company Status
Private & Independent
Mailing Address
701 Pike St. 1500
Seattle, WA 98101
Email Address
Avalyn is developing inhaled approaches to treat people with severe respiratory disease. Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases.
Avalyn Pharma LinkedIn Company Profile
Social Media
Avalyn Pharma Company Twitter Account
Company News
Avalyn Pharma News
Avalyn Pharma on Facebook
Avalyn Pharma on YouTube

Management Team

Email & Social
Chief Executive Officer
Bruce Montgomery
  Bruce Montgomery LinkedIn Profile  Bruce Montgomery Twitter Account  Bruce Montgomery News  Bruce Montgomery on Facebook
Chief Scientific Officer
Mark Surber
  Mark Surber LinkedIn Profile  Mark Surber Twitter Account  Mark Surber News  Mark Surber on Facebook
VP - Finance
Nancy McKinley
  Nancy McKinley LinkedIn Profile  Nancy McKinley Twitter Account  Nancy McKinley News  Nancy McKinley on Facebook
VP - Operations
Kelly Otto
  Kelly Otto LinkedIn Profile  Kelly Otto Twitter Account  Kelly Otto News  Kelly Otto on Facebook
VP - Product Management
Stephen Pham
  Stephen Pham LinkedIn Profile  Stephen Pham Twitter Account  Stephen Pham News  Stephen Pham on Facebook



Browse more venture capital transactions:

Prev: 9/26/2023: Adela venture capital transaction
Next: 9/27/2023: Axial Shift venture capital transaction


Share this article


Where The Data Comes From

Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary